Up 19.2%, Is Viking Therapeutics Stock Still a Buy?
Can the stock march even higher after its recent rally?
Viking Therapeutics
VKTX
VKTX
$7.33
-$0.59
-7.4%
BATS BZX Real Time Price as of November 19, 2019, 4:00 p.m. EST
View Interactive VKTX Charts
Viking Therapeutics, Inc.
News & Analysis: Viking Therapeutics
The Fool has written over 100 articles on Viking Therapeutics.
Why Viking Therapeutics Stock Soared Today
The biotech's Q3 update fired up investors.
Better Buy: Intercept Pharmaceuticals vs. Viking Therapeutics
The biotech rivals each aim to dominate the treatment market for non-alcoholic steatohepatitis (NASH).
3 Top Small-Cap Stocks to Buy in August
These small-cap stocks hold the potential to deliver big-time returns.
Is Viking Therapeutics a Buy?
What you need to know about this high-risk, high-reward biotech stock.
Viking Therapeutics Inc (VKTX) Q2 2019 Earnings Call Transcript
VKTX earnings call for the period ending June 30, 2019.
Where Will Viking Therapeutics Be in 1 Year?
It's one of the more promising companies in the race to develop a successful NASH treatment. Will patient investors be rewarded?
3 Stocks to Buy and Hold for the Next 50 Years
The catalysts these companies enjoy could translate into big returns for shareholders in the coming decades.
3 Small-Cap Biotech Stocks You Can Buy Right Now
They're risky. You'll have to wait years before any significant revenue comes in. But these biotech stocks could be huge winners.
Viking Therapeutics Inc (VKTX) Q1 2019 Earnings Call Transcript
VKTX earnings call for the period ending March 31, 2019.
